The results showed that FGD5-AS1 was highly expressed in Brain low-grade glioma (LGG), GBM, PAAD and thymic carcinoma (THYM), and we also observed low expression of FGD5-AS1 in KIRC, which is consistent with the above finding (Figure 1) [20]. This evidence concerns the gene FGD5 and thymic carcinoma.